Clinical Trial

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

Study acronym: OA07
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to test the safety and efficacy of study drug for the treatment of knee pain due to osteoarthritis (OA). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.
Trial Details
NCT Number NCT07641517
Lead Sponsor Eli Lilly and Company
Conditions Osteoarthritis, Knee, Chronic Pain
Enrollment 150 participants
Start Date 2026-07
Primary Completion 2027-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-11